Dr. Bosworth is a health services researcher and a Professor of Medicine, Psychiatry, and Nursing at Duke University Medical Center and Adjunct Professor in Health Policy and Administration at the School of Public Health at the University of North Carolina at Chapel Hill. He is involved with the development of the new Department of Population Health Sciences at Duke University. His research interests comprise three overarching areas of research: 1) clinical research that provides knowledge for improving patients’ treatment adherence and self-management in chronic care; 2) translation research to improve access to quality of care; and 3) eliminate health care disparities.

Dr. Bosworth was the recipient of an American Heart Association established investigator award, the 2013 VA Undersecretary Award for Outstanding Achievement in Health Services Research (The annual award is the highest honor for VA health services researchers), and a VA Senior Career Scientist Award. In terms of medication adherence, Dr. Bosworth has been developing and implementing tailored interventions to reduce the burden of chronic diseases. These trials focus on motivating individuals to initiate health behaviors and sustaining them long term and includes using various methods of engagement and including various members of the healthcare system (e.g., pharmacists and nurses). He has led over 30 trials and participated in another 50 resulting in over 270 peer reviewed publications and four books. This work has been or is being implemented in multiple arenas including Pharma patient support programs, Medicaid of North Carolina, The United Kingdom National Health System Direct, Kaiser Health care system, and the Veterans Affairs. He will talk about the state of medication adherence including population and patient-centered methods for medication adherence, the role of policy, potential for digital solutions and provide some specific recommendations to improve medication adherence and subsequent outcomes for individuals.

Dr. Bosworth is a health services researcher and a Professor of Medicine, Psychiatry, and Nursing at Duke University Medical Center and Adjunct Professor in Health Policy and Administration at the School of Public Health at the University of North Carolina at Chapel Hill. He is involved with the development of the new Department of Population Health Sciences at Duke University. His research interests comprise three overarching areas of research: 1) clinical research that provides knowledge for improving patients’ treatment adherence and self-management in chronic care; 2) translation research to improve access to quality of care; and 3) eliminate health care disparities.

Dr. Bosworth was the recipient of an American Heart Association established investigator award, the 2013 VA Undersecretary Award for Outstanding Achievement in Health Services Research (The annual award is the highest honor for VA health services researchers), and a VA Senior Career Scientist Award. In terms of medication adherence, Dr. Bosworth has been developing and implementing tailored interventions to reduce the burden of chronic diseases. These trials focus on motivating individuals to initiate health behaviors and sustaining them long term and includes using various methods of engagement and including various members of the healthcare system (e.g., pharmacists and nurses). He has led over 30 trials and participated in another 50 resulting in over 270 peer reviewed publications and four books. This work has been or is being implemented in multiple arenas including Pharma patient support programs, Medicaid of North Carolina, The United Kingdom National Health System Direct, Kaiser Health care system, and the Veterans Affairs. He will talk about the state of medication adherence including population and patient-centered methods for medication adherence, the role of policy, potential for digital solutions and provide some specific recommendations to improve medication adherence and subsequent outcomes for individuals.

Dr. Bosworth is a health services researcher and a Professor of Medicine, Psychiatry, and Nursing at Duke University Medical Center and Adjunct Professor in Health Policy and Administration at the School of Public Health at the University of North Carolina at Chapel Hill. He is involved with the development of the new Department of Population Health Sciences at Duke University. His research interests comprise three overarching areas of research: 1) clinical research that provides knowledge for improving patients’ treatment adherence and self-management in chronic care; 2) translation research to improve access to quality of care; and 3) eliminate health care disparities.

Dr. Bosworth was the recipient of an American Heart Association established investigator award, the 2013 VA Undersecretary Award for Outstanding Achievement in Health Services Research (The annual award is the highest honor for VA health services researchers), and a VA Senior Career Scientist Award. In terms of medication adherence, Dr. Bosworth has been developing and implementing tailored interventions to reduce the burden of chronic diseases. These trials focus on motivating individuals to initiate health behaviors and sustaining them long term and includes using various methods of engagement and including various members of the healthcare system (e.g., pharmacists and nurses). He has led over 30 trials and participated in another 50 resulting in over 270 peer reviewed publications and four books. This work has been or is being implemented in multiple arenas including Pharma patient support programs, Medicaid of North Carolina, The United Kingdom National Health System Direct, Kaiser Health care system, and the Veterans Affairs. He will talk about the state of medication adherence including population and patient-centered methods for medication adherence, the role of policy, potential for digital solutions and provide some specific recommendations to improve medication adherence and subsequent outcomes for individuals.

Dr. Bosworth is a health services researcher and a Professor of Medicine, Psychiatry, and Nursing at Duke University Medical Center and Adjunct Professor in Health Policy and Administration at the School of Public Health at the University of North Carolina at Chapel Hill. He is involved with the development of the new Department of Population Health Sciences at Duke University. His research interests comprise three overarching areas of research: 1) clinical research that provides knowledge for improving patients’ treatment adherence and self-management in chronic care; 2) translation research to improve access to quality of care; and 3) eliminate health care disparities.

Dr. Bosworth was the recipient of an American Heart Association established investigator award, the 2013 VA Undersecretary Award for Outstanding Achievement in Health Services Research (The annual award is the highest honor for VA health services researchers), and a VA Senior Career Scientist Award. In terms of medication adherence, Dr. Bosworth has been developing and implementing tailored interventions to reduce the burden of chronic diseases. These trials focus on motivating individuals to initiate health behaviors and sustaining them long term and includes using various methods of engagement and including various members of the healthcare system (e.g., pharmacists and nurses). He has led over 30 trials and participated in another 50 resulting in over 270 peer reviewed publications and four books. This work has been or is being implemented in multiple arenas including Pharma patient support programs, Medicaid of North Carolina, The United Kingdom National Health System Direct, Kaiser Health care system, and the Veterans Affairs. He will talk about the state of medication adherence including population and patient-centered methods for medication adherence, the role of policy, potential for digital solutions and provide some specific recommendations to improve medication adherence and subsequent outcomes for individuals.

Dr. Bosworth is a health services researcher and a Professor of Medicine, Psychiatry, and Nursing at Duke University Medical Center and Adjunct Professor in Health Policy and Administration at the School of Public Health at the University of North Carolina at Chapel Hill. He is involved with the development of the new Department of Population Health Sciences at Duke University. His research interests comprise three overarching areas of research: 1) clinical research that provides knowledge for improving patients’ treatment adherence and self-management in chronic care; 2) translation research to improve access to quality of care; and 3) eliminate health care disparities.

Dr. Bosworth was the recipient of an American Heart Association established investigator award, the 2013 VA Undersecretary Award for Outstanding Achievement in Health Services Research (The annual award is the highest honor for VA health services researchers), and a VA Senior Career Scientist Award. In terms of medication adherence, Dr. Bosworth has been developing and implementing tailored interventions to reduce the burden of chronic diseases. These trials focus on motivating individuals to initiate health behaviors and sustaining them long term and includes using various methods of engagement and including various members of the healthcare system (e.g., pharmacists and nurses). He has led over 30 trials and participated in another 50 resulting in over 270 peer reviewed publications and four books. This work has been or is being implemented in multiple arenas including Pharma patient support programs, Medicaid of North Carolina, The United Kingdom National Health System Direct, Kaiser Health care system, and the Veterans Affairs. He will talk about the state of medication adherence including population and patient-centered methods for medication adherence, the role of policy, potential for digital solutions and provide some specific recommendations to improve medication adherence and subsequent outcomes for individuals.

Dr. Bosworth is a health services researcher and a Professor of Medicine, Psychiatry, and Nursing at Duke University Medical Center and Adjunct Professor in Health Policy and Administration at the School of Public Health at the University of North Carolina at Chapel Hill. He is involved with the development of the new Department of Population Health Sciences at Duke University. His research interests comprise three overarching areas of research: 1) clinical research that provides knowledge for improving patients’ treatment adherence and self-management in chronic care; 2) translation research to improve access to quality of care; and 3) eliminate health care disparities.

Dr. Bosworth was the recipient of an American Heart Association established investigator award, the 2013 VA Undersecretary Award for Outstanding Achievement in Health Services Research (The annual award is the highest honor for VA health services researchers), and a VA Senior Career Scientist Award. In terms of medication adherence, Dr. Bosworth has been developing and implementing tailored interventions to reduce the burden of chronic diseases. These trials focus on motivating individuals to initiate health behaviors and sustaining them long term and includes using various methods of engagement and including various members of the healthcare system (e.g., pharmacists and nurses). He has led over 30 trials and participated in another 50 resulting in over 270 peer reviewed publications and four books. This work has been or is being implemented in multiple arenas including Pharma patient support programs, Medicaid of North Carolina, The United Kingdom National Health System Direct, Kaiser Health care system, and the Veterans Affairs. He will talk about the state of medication adherence including population and patient-centered methods for medication adherence, the role of policy, potential for digital solutions and provide some specific recommendations to improve medication adherence and subsequent outcomes for individuals.

Lisa is the strategic lead for promoting and building patient centered products, and solutions that fit into people’s lives and improve healthcare outcomes. This includes leveraging current programs such as patient support programs, as well as creation and development of new mechanisms for improving patient outcomes though both internal and external collaborations. Lisa’s role is to build a global platform for patient centered capabilities to catalyze the development, measurement, adaptation, and amplification of solutions that improve outcomes of interest to patients and their families, providers, and payers.

Lisa comes to Sanofi as a pharmaceutical executive with expertise in outcomes research and public health. Most recently, she has been an entrepreneur, catalyzing the development of low cost “disruptive” medical devices to promote public health and a strategy consultant, advising biopharmaceutical companies on product and service development and on evidence generation strategies to meet the needs of patients, providers, payers and policy makers. In Lisa’s previous roles at Pfizer as Vice President of Medical Affairs and Vice President of Global Outcomes Research, she developed evidence from clinical trials, observational studies, and “real world” analyses to support product value assessment throughout the product lifecycle as well as customer-based assessment of both products and services. Additionally, she has created innovative patient focused, multi-sector partnerships to promote health care access, quality and outcomes in numerous populations, ranging from maternal and infant health to the elderly.

Lisa has a B.S. in Biology from the Massachusetts Institute of Technology (M.I.T.) and an M.B.A. in health care management from Wharton School of the University of Pennsylvania; she earned an M.D. and M.P.H. degrees from Johns Hopkins and is board certified in pediatrics.

Lisa is the strategic lead for promoting and building patient centered products, and solutions that fit into people’s lives and improve healthcare outcomes. This includes leveraging current programs such as patient support programs, as well as creation and development of new mechanisms for improving patient outcomes though both internal and external collaborations. Lisa’s role is to build a global platform for patient centered capabilities to catalyze the development, measurement, adaptation, and amplification of solutions that improve outcomes of interest to patients and their families, providers, and payers.

Lisa comes to Sanofi as a pharmaceutical executive with expertise in outcomes research and public health. Most recently, she has been an entrepreneur, catalyzing the development of low cost “disruptive” medical devices to promote public health and a strategy consultant, advising biopharmaceutical companies on product and service development and on evidence generation strategies to meet the needs of patients, providers, payers and policy makers. In Lisa’s previous roles at Pfizer as Vice President of Medical Affairs and Vice President of Global Outcomes Research, she developed evidence from clinical trials, observational studies, and “real world” analyses to support product value assessment throughout the product lifecycle as well as customer-based assessment of both products and services. Additionally, she has created innovative patient focused, multi-sector partnerships to promote health care access, quality and outcomes in numerous populations, ranging from maternal and infant health to the elderly.

Lisa has a B.S. in Biology from the Massachusetts Institute of Technology (M.I.T.) and an M.B.A. in health care management from Wharton School of the University of Pennsylvania; she earned an M.D. and M.P.H. degrees from Johns Hopkins and is board certified in pediatrics.

Lisa is the strategic lead for promoting and building patient centered products, and solutions that fit into people’s lives and improve healthcare outcomes. This includes leveraging current programs such as patient support programs, as well as creation and development of new mechanisms for improving patient outcomes though both internal and external collaborations. Lisa’s role is to build a global platform for patient centered capabilities to catalyze the development, measurement, adaptation, and amplification of solutions that improve outcomes of interest to patients and their families, providers, and payers.

Lisa comes to Sanofi as a pharmaceutical executive with expertise in outcomes research and public health. Most recently, she has been an entrepreneur, catalyzing the development of low cost “disruptive” medical devices to promote public health and a strategy consultant, advising biopharmaceutical companies on product and service development and on evidence generation strategies to meet the needs of patients, providers, payers and policy makers. In Lisa’s previous roles at Pfizer as Vice President of Medical Affairs and Vice President of Global Outcomes Research, she developed evidence from clinical trials, observational studies, and “real world” analyses to support product value assessment throughout the product lifecycle as well as customer-based assessment of both products and services. Additionally, she has created innovative patient focused, multi-sector partnerships to promote health care access, quality and outcomes in numerous populations, ranging from maternal and infant health to the elderly.

Lisa has a B.S. in Biology from the Massachusetts Institute of Technology (M.I.T.) and an M.B.A. in health care management from Wharton School of the University of Pennsylvania; she earned an M.D. and M.P.H. degrees from Johns Hopkins and is board certified in pediatrics.

Lisa is the strategic lead for promoting and building patient centered products, and solutions that fit into people’s lives and improve healthcare outcomes. This includes leveraging current programs such as patient support programs, as well as creation and development of new mechanisms for improving patient outcomes though both internal and external collaborations. Lisa’s role is to build a global platform for patient centered capabilities to catalyze the development, measurement, adaptation, and amplification of solutions that improve outcomes of interest to patients and their families, providers, and payers.

Lisa comes to Sanofi as a pharmaceutical executive with expertise in outcomes research and public health. Most recently, she has been an entrepreneur, catalyzing the development of low cost “disruptive” medical devices to promote public health and a strategy consultant, advising biopharmaceutical companies on product and service development and on evidence generation strategies to meet the needs of patients, providers, payers and policy makers. In Lisa’s previous roles at Pfizer as Vice President of Medical Affairs and Vice President of Global Outcomes Research, she developed evidence from clinical trials, observational studies, and “real world” analyses to support product value assessment throughout the product lifecycle as well as customer-based assessment of both products and services. Additionally, she has created innovative patient focused, multi-sector partnerships to promote health care access, quality and outcomes in numerous populations, ranging from maternal and infant health to the elderly.

Lisa has a B.S. in Biology from the Massachusetts Institute of Technology (M.I.T.) and an M.B.A. in health care management from Wharton School of the University of Pennsylvania; she earned an M.D. and M.P.H. degrees from Johns Hopkins and is board certified in pediatrics.

Lisa is the strategic lead for promoting and building patient centered products, and solutions that fit into people’s lives and improve healthcare outcomes. This includes leveraging current programs such as patient support programs, as well as creation and development of new mechanisms for improving patient outcomes though both internal and external collaborations. Lisa’s role is to build a global platform for patient centered capabilities to catalyze the development, measurement, adaptation, and amplification of solutions that improve outcomes of interest to patients and their families, providers, and payers.

Lisa comes to Sanofi as a pharmaceutical executive with expertise in outcomes research and public health. Most recently, she has been an entrepreneur, catalyzing the development of low cost “disruptive” medical devices to promote public health and a strategy consultant, advising biopharmaceutical companies on product and service development and on evidence generation strategies to meet the needs of patients, providers, payers and policy makers. In Lisa’s previous roles at Pfizer as Vice President of Medical Affairs and Vice President of Global Outcomes Research, she developed evidence from clinical trials, observational studies, and “real world” analyses to support product value assessment throughout the product lifecycle as well as customer-based assessment of both products and services. Additionally, she has created innovative patient focused, multi-sector partnerships to promote health care access, quality and outcomes in numerous populations, ranging from maternal and infant health to the elderly.

Lisa has a B.S. in Biology from the Massachusetts Institute of Technology (M.I.T.) and an M.B.A. in health care management from Wharton School of the University of Pennsylvania; she earned an M.D. and M.P.H. degrees from Johns Hopkins and is board certified in pediatrics.

Lisa is the strategic lead for promoting and building patient centered products, and solutions that fit into people’s lives and improve healthcare outcomes. This includes leveraging current programs such as patient support programs, as well as creation and development of new mechanisms for improving patient outcomes though both internal and external collaborations. Lisa’s role is to build a global platform for patient centered capabilities to catalyze the development, measurement, adaptation, and amplification of solutions that improve outcomes of interest to patients and their families, providers, and payers.

Lisa comes to Sanofi as a pharmaceutical executive with expertise in outcomes research and public health. Most recently, she has been an entrepreneur, catalyzing the development of low cost “disruptive” medical devices to promote public health and a strategy consultant, advising biopharmaceutical companies on product and service development and on evidence generation strategies to meet the needs of patients, providers, payers and policy makers. In Lisa’s previous roles at Pfizer as Vice President of Medical Affairs and Vice President of Global Outcomes Research, she developed evidence from clinical trials, observational studies, and “real world” analyses to support product value assessment throughout the product lifecycle as well as customer-based assessment of both products and services. Additionally, she has created innovative patient focused, multi-sector partnerships to promote health care access, quality and outcomes in numerous populations, ranging from maternal and infant health to the elderly.

Lisa has a B.S. in Biology from the Massachusetts Institute of Technology (M.I.T.) and an M.B.A. in health care management from Wharton School of the University of Pennsylvania; she earned an M.D. and M.P.H. degrees from Johns Hopkins and is board certified in pediatrics.

Lisa is the strategic lead for promoting and building patient centered products, and solutions that fit into people’s lives and improve healthcare outcomes. This includes leveraging current programs such as patient support programs, as well as creation and development of new mechanisms for improving patient outcomes though both internal and external collaborations. Lisa’s role is to build a global platform for patient centered capabilities to catalyze the development, measurement, adaptation, and amplification of solutions that improve outcomes of interest to patients and their families, providers, and payers.

Lisa comes to Sanofi as a pharmaceutical executive with expertise in outcomes research and public health. Most recently, she has been an entrepreneur, catalyzing the development of low cost “disruptive” medical devices to promote public health and a strategy consultant, advising biopharmaceutical companies on product and service development and on evidence generation strategies to meet the needs of patients, providers, payers and policy makers. In Lisa’s previous roles at Pfizer as Vice President of Medical Affairs and Vice President of Global Outcomes Research, she developed evidence from clinical trials, observational studies, and “real world” analyses to support product value assessment throughout the product lifecycle as well as customer-based assessment of both products and services. Additionally, she has created innovative patient focused, multi-sector partnerships to promote health care access, quality and outcomes in numerous populations, ranging from maternal and infant health to the elderly.

Lisa has a B.S. in Biology from the Massachusetts Institute of Technology (M.I.T.) and an M.B.A. in health care management from Wharton School of the University of Pennsylvania; she earned an M.D. and M.P.H. degrees from Johns Hopkins and is board certified in pediatrics.

Lisa is the strategic lead for promoting and building patient centered products, and solutions that fit into people’s lives and improve healthcare outcomes. This includes leveraging current programs such as patient support programs, as well as creation and development of new mechanisms for improving patient outcomes though both internal and external collaborations. Lisa’s role is to build a global platform for patient centered capabilities to catalyze the development, measurement, adaptation, and amplification of solutions that improve outcomes of interest to patients and their families, providers, and payers.

Lisa comes to Sanofi as a pharmaceutical executive with expertise in outcomes research and public health. Most recently, she has been an entrepreneur, catalyzing the development of low cost “disruptive” medical devices to promote public health and a strategy consultant, advising biopharmaceutical companies on product and service development and on evidence generation strategies to meet the needs of patients, providers, payers and policy makers. In Lisa’s previous roles at Pfizer as Vice President of Medical Affairs and Vice President of Global Outcomes Research, she developed evidence from clinical trials, observational studies, and “real world” analyses to support product value assessment throughout the product lifecycle as well as customer-based assessment of both products and services. Additionally, she has created innovative patient focused, multi-sector partnerships to promote health care access, quality and outcomes in numerous populations, ranging from maternal and infant health to the elderly.

Lisa has a B.S. in Biology from the Massachusetts Institute of Technology (M.I.T.) and an M.B.A. in health care management from Wharton School of the University of Pennsylvania; she earned an M.D. and M.P.H. degrees from Johns Hopkins and is board certified in pediatrics.

Lisa is the strategic lead for promoting and building patient centered products, and solutions that fit into people’s lives and improve healthcare outcomes. This includes leveraging current programs such as patient support programs, as well as creation and development of new mechanisms for improving patient outcomes though both internal and external collaborations. Lisa’s role is to build a global platform for patient centered capabilities to catalyze the development, measurement, adaptation, and amplification of solutions that improve outcomes of interest to patients and their families, providers, and payers.

Lisa comes to Sanofi as a pharmaceutical executive with expertise in outcomes research and public health. Most recently, she has been an entrepreneur, catalyzing the development of low cost “disruptive” medical devices to promote public health and a strategy consultant, advising biopharmaceutical companies on product and service development and on evidence generation strategies to meet the needs of patients, providers, payers and policy makers. In Lisa’s previous roles at Pfizer as Vice President of Medical Affairs and Vice President of Global Outcomes Research, she developed evidence from clinical trials, observational studies, and “real world” analyses to support product value assessment throughout the product lifecycle as well as customer-based assessment of both products and services. Additionally, she has created innovative patient focused, multi-sector partnerships to promote health care access, quality and outcomes in numerous populations, ranging from maternal and infant health to the elderly.

Lisa has a B.S. in Biology from the Massachusetts Institute of Technology (M.I.T.) and an M.B.A. in health care management from Wharton School of the University of Pennsylvania; she earned an M.D. and M.P.H. degrees from Johns Hopkins and is board certified in pediatrics.

Lisa is the strategic lead for promoting and building patient centered products, and solutions that fit into people’s lives and improve healthcare outcomes. This includes leveraging current programs such as patient support programs, as well as creation and development of new mechanisms for improving patient outcomes though both internal and external collaborations. Lisa’s role is to build a global platform for patient centered capabilities to catalyze the development, measurement, adaptation, and amplification of solutions that improve outcomes of interest to patients and their families, providers, and payers.

Lisa comes to Sanofi as a pharmaceutical executive with expertise in outcomes research and public health. Most recently, she has been an entrepreneur, catalyzing the development of low cost “disruptive” medical devices to promote public health and a strategy consultant, advising biopharmaceutical companies on product and service development and on evidence generation strategies to meet the needs of patients, providers, payers and policy makers. In Lisa’s previous roles at Pfizer as Vice President of Medical Affairs and Vice President of Global Outcomes Research, she developed evidence from clinical trials, observational studies, and “real world” analyses to support product value assessment throughout the product lifecycle as well as customer-based assessment of both products and services. Additionally, she has created innovative patient focused, multi-sector partnerships to promote health care access, quality and outcomes in numerous populations, ranging from maternal and infant health to the elderly.

Lisa has a B.S. in Biology from the Massachusetts Institute of Technology (M.I.T.) and an M.B.A. in health care management from Wharton School of the University of Pennsylvania; she earned an M.D. and M.P.H. degrees from Johns Hopkins and is board certified in pediatrics.